CHOP is the acronym for a chemotherapy regimen used in the treatment of non-Hodgkin lymphoma.

Its use has been investigated, primarily in the treatment of follicular lymphoma.

This summary includes information on the treatment of non-Hodgkin lymphoma during pregnancy.

This summary is about the treatment of adult non-Hodgkin lymphoma.

Delaying treatment of aggressive lymphoma until after the baby is born may lessen the mother's chance of survival.

Afutuzumab is a monoclonal antibody being developed by Hoffmann-La Roche Inc. for the treatment of lymphoma.

Tositumomab is a drug for the treatment of follicular lymphoma.

In 2010 it was approved by the European Commission for maintenance treatment after initial treatment of follicular lymphoma.

These medications were the first agents of what is known as radioimmunotherapy, and they were approved for the treatment of refractory non-Hodgkins lymphoma.

Autologus bone marrow transplantion is currently being investigated in the treatment of hepatosplenic lymphoma.